{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:40:17Z","timestamp":1787064017151,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003213","name":"Beijing Municipal Education Commission","doi-asserted-by":"publisher","award":["KM202110025020"],"award-info":[{"award-number":["KM202110025020"]}],"id":[{"id":"10.13039\/501100003213","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003213","name":"Beijing Municipal Education Commission","doi-asserted-by":"publisher","award":["+2021ZD0204300"],"award-info":[{"award-number":["+2021ZD0204300"]}],"id":[{"id":"10.13039\/501100003213","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1101403"],"award-info":[{"award-number":["2021YFA1101403"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82090043"],"award-info":[{"award-number":["82090043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001258"],"award-info":[{"award-number":["82001258"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.xcrm.2026.102836","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T14:55:53Z","timestamp":1779980153000},"page":"102836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intravenous human umbilical cord-derived mesenchymal stem cell transplantation for ischemic stroke (MERIT): A phase 1 trial"],"prefix":"10.1016","volume":"7","author":[{"given":"Lili","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoting","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiquan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianmei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Jolkkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Boltze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-5434","authenticated-orcid":false,"given":"Junwei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102836_bib1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"20","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.xcrm.2026.102836_bib2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/STROKEAHA.122.040073","article-title":"Projected global trends in ischemic stroke incidence, deaths and disability-adjusted life years from 2020 to 2030","volume":"54","author":"Pu","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.xcrm.2026.102836_bib3","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.xcrm.2026.102836_bib4","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1007\/s00415-020-10138-5","article-title":"Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential","volume":"268","author":"Li","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.xcrm.2026.102836_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ana.25493","article-title":"Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy?","volume":"86","author":"Cui","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xcrm.2026.102836_bib6","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1161\/STROKEAHA.114.007803","article-title":"Stem cell-based tissue replacement after stroke: factual necessity or notorious fiction?","volume":"46","author":"Janowski","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.xcrm.2026.102836_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuroscience.2024.05.009","article-title":"Neurorestorative approaches for ischemic stroke: challenges, opportunities, and recent advances","volume":"550","author":"Mich\u00f3r","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.xcrm.2026.102836_bib8","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1161\/STROKEAHA.119.026318","article-title":"Phase I\/II study of safety and preliminary efficacy of intravenous allogeneic mesenchymal stem cells in chronic stroke","volume":"50","author":"Levy","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.xcrm.2026.102836_bib9","doi-asserted-by":"crossref","first-page":"e1012","DOI":"10.1212\/WNL.0000000000011440","article-title":"Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke","volume":"96","author":"Chung","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.xcrm.2026.102836_bib10","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s12975-020-00787-z","article-title":"Autologous mesenchymal stem cells improve motor recovery in subacute ischemic stroke: a randomized clinical trial","volume":"11","author":"Jaillard","year":"2020","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.xcrm.2026.102836_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/09636897221083863","article-title":"Final results of allogeneic adipose tissue-derived mesenchymal stem cells in acute ischemic stroke (AMASCIS): a phase II, randomized, double-blind, placebo-controlled, single-center, pilot clinical trial","volume":"31","author":"de Celis-Ruiz","year":"2022","journal-title":"Cell Transplant."},{"key":"10.1016\/j.xcrm.2026.102836_bib12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1474-4422(17)30046-7","article-title":"Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"16","author":"Hess","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.xcrm.2026.102836_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/jamaneurol.2023.5200","article-title":"Allogeneic Stem cell therapy for acute ischemic stroke: the phase 2\/3 TREASURE randomized clinical trial","volume":"81","author":"Houkin","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.xcrm.2026.102836_bib14","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1161\/STROKEAHA.112.659409","article-title":"Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial","volume":"43","author":"Moniche","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.xcrm.2026.102836_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3171\/jns.2005.103.1.0038","article-title":"Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial","volume":"103","author":"Kondziolka","year":"2005","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.xcrm.2026.102836_bib16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(16)30513-X","article-title":"Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study","volume":"388","author":"Kalladka","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.102836_bib17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cell."},{"key":"10.1016\/j.xcrm.2026.102836_bib18","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1161\/STROKEAHA.116.012995","article-title":"Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1\/2a study","volume":"47","author":"Steinberg","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.xcrm.2026.102836_bib19","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1038\/s41467-023-39958-5","article-title":"Multi-omics analysis of human mesenchymal stem cells shows cell aging that alters immunomodulatory activity through the downregulation of PD-L1","volume":"14","author":"Gao","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102836_bib20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jcyt.2018.11.008","article-title":"Mesenchymal stromal cells from infants with simple polydactyly modulate immune responses more efficiently than adult mesenchymal stromal cells","volume":"21","author":"Myneni","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.xcrm.2026.102836_bib21","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1038\/s41467-024-46259-y","article-title":"Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial","volume":"15","author":"Bydon","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102836_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41392-024-01793-5","article-title":"Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2026.102836_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2217\/rme.13.2","article-title":"Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients","volume":"8","author":"Rosado-de-Castro","year":"2013","journal-title":"Regen. Med."},{"key":"10.1016\/j.xcrm.2026.102836_bib24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/CIRCULATIONAHA.117.030659","article-title":"A phase 2 randomized, sham-controlled trial of internal carotid artery infusion of autologous bone marrow-derived ALD-401 cells in patients with recent stable ischemic stroke (RECOVER-Stroke)","volume":"139","author":"Savitz","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2026.102836_bib25","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","article-title":"Measurements of acute cerebral infarction: a clinical examination scale","volume":"20","author":"Brott","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.xcrm.2026.102836_bib26","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3349\/ymj.2013.54.5.1293","article-title":"Familial occurrence of pulmonary embolism after intravenous, adipose tissue-derived stem cell therapy","volume":"54","author":"Jung","year":"2013","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.xcrm.2026.102836_bib27","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/stem.1111","article-title":"Are therapeutic human mesenchymal stromal cells compatible with human blood?","volume":"30","author":"Moll","year":"2012","journal-title":"Stem Cell."},{"key":"10.1016\/j.xcrm.2026.102836_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fneur.2015.00155","article-title":"The dark side of the force-constraints and complications of cell therapies for stroke","volume":"6","author":"Boltze","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.xcrm.2026.102836_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.seizure.2024.06.011","article-title":"Late onset epilepsy and stroke: diagnosis, pathogenesis and prevention","volume":"128","author":"Stefan","year":"2025","journal-title":"Seizure"},{"key":"10.1016\/j.xcrm.2026.102836_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40266-021-00837-7","article-title":"Seizures and epilepsy after stroke: epidemiology, biomarkers and management","volume":"38","author":"Galovic","year":"2021","journal-title":"Drugs Aging"},{"key":"10.1016\/j.xcrm.2026.102836_bib31","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/stcltm\/szae040","article-title":"Efficacy and safety of mesenchymal stem cell therapies for ischemic stroke: a systematic review and meta-analysis","volume":"13","author":"Shen","year":"2024","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102836_bib32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1747-4949.2012.00797.x","article-title":"Stem cell-based therapy for experimental stroke: a systematic review and meta-analysis","volume":"7","author":"Lees","year":"2012","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.xcrm.2026.102836_bib33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/cns.12216","article-title":"Timing and dose regimens of marrow mesenchymal stem cell transplantation affect the outcomes and neuroinflammatory response after ischemic stroke","volume":"20","author":"Wang","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.xcrm.2026.102836_bib34","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/jnr.22614","article-title":"Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke","volume":"89","author":"Yang","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.xcrm.2026.102836_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clineuro.2016.04.011","article-title":"Effect of stem cell-based therapy for ischemic stroke treatment: A meta-analysis","volume":"146","author":"Wang","year":"2016","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.xcrm.2026.102836_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1474-4422(22)00526-9","article-title":"Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial","volume":"22","author":"Moniche","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.xcrm.2026.102836_bib37","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102836_bib38","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4049\/jimmunol.0902007","article-title":"Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype","volume":"185","author":"Ghannam","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102836_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12712","article-title":"Immune modulation by mesenchymal stem cells","volume":"53","author":"Jiang","year":"2020","journal-title":"Cell Prolif."},{"key":"10.1016\/j.xcrm.2026.102836_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13267","article-title":"Immunogenicity of mesenchymal stromal\/stem cells","volume":"97","author":"Chen","year":"2023","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102836_bib41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.xcrm.2026.102836_bib42","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/00004424-200011000-00007","article-title":"Arteriovenous malformations: assessment of gliotic and ischemic changes with fluid-attenuated inversion-recovery MRI","volume":"35","author":"Essig","year":"2000","journal-title":"Investig. Radiol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:46:31Z","timestamp":1785883591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126002533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666379126002533"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102836","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous human umbilical cord-derived mesenchymal stem cell transplantation for ischemic stroke (MERIT): A phase 1 trial","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102836"}}